Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas

Cancer Treat Rep. 1977 Sep;61(6):1023-7.


The Ann Arbor staging classification has proved to be valuable for Hodgkin's disease. When proposed in 1971 it was thought that it could also be applied to the non-Hodgkin's lymphomas. The diversity of the non-Hodgkin's groups, the continued evolution of histopathologic classifications, and the great frequency of advanced disease in the lymphocytic subgroups make the Ann Arbor classification of only limited value for the non-Hodgkin's lymphomas.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Marrow / pathology
  • Evaluation Studies as Topic
  • Humans
  • Lymphoma / classification*
  • Lymphoma / pathology
  • Neoplasm Staging